These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31375691)

  • 1. Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis.
    Hušáková M; Bay-Jensen AC; Forejtová Š; Zegzulková K; Tomčík M; Gregová M; Bubová K; Hořínková J; Gatterová J; Pavelka K; Siebuhr AS
    Sci Rep; 2019 Aug; 9(1):11218. PubMed ID: 31375691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I and III collagen turnover is increased in axial spondyloarthritis and psoriatic arthritis. Associations with disease activity and diagnostic capacity.
    Gudmann NS; Siebuhr AS; Christensen AF; Ejstrup L; Sørensen GL; Loft AG; Karsdal MA; Bay-Jensen AC; Munk HL; Junker P
    Clin Exp Rheumatol; 2017; 35(4):653-659. PubMed ID: 28240584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
    Levitova A; Hulejova H; Spiritovic M; Pavelka K; Senolt L; Husakova M
    Arthritis Res Ther; 2016 Nov; 18(1):275. PubMed ID: 27887637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular matrix protein turnover markers are associated with axial spondyloarthritis-a comparison with postpartum women and other non-axial spondyloarthritis controls with or without back pain.
    Port H; Nielsen SH; Madsen SF; Bay-Jensen AC; Karsdal M; Seven S; Sørensen IJ; Morsel-Carlsen L; Østergaard M; Pedersen SJ
    Arthritis Res Ther; 2022 Jun; 24(1):152. PubMed ID: 35739562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of extracellular matrix metabolites are associated with changes in Ankylosing Spondylitis Disease Activity Score and MRI inflammation scores in patients with axial spondyloarthritis during TNF inhibitor therapy.
    Holm Nielsen S; Sun S; Bay-Jensen AC; Karsdal M; Sørensen IJ; Weber U; Loft AG; Kollerup G; Thamsborg G; Madsen OR; Møller J; Østergaard M; Pedersen SJ
    Arthritis Res Ther; 2022 Dec; 24(1):279. PubMed ID: 36564778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive correlation between inflammation on sacroiliac joint MRI and serum C-terminal telopeptide of type-I collagen in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis.
    Kang KY; Jung JY; Hong YS; Ju JH; Park SH
    Clin Exp Rheumatol; 2017; 35(3):415-422. PubMed ID: 27974096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolites of C-reactive protein and vimentin are associated with disease activity of axial spondyloarthritis.
    Siebuhr AS; Hušaková M; Forejtová S; Zegzulková K; Tomčik M; Urbanová M; Grobelná K; Gatterová J; Bay-Jensen AC; Pavelka K
    Clin Exp Rheumatol; 2019; 37(3):358-366. PubMed ID: 30767876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?
    Kiltz U; Baraliakos X; Karakostas P; Igelmann M; Kalthoff L; Klink C; Krause D; Schmitz-Bortz E; Flörecke M; Bollow M; Braun J
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1415-22. PubMed ID: 22505331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort.
    Olofsson T; Lindqvist E; Mogard E; Andréasson K; Marsal J; Geijer M; Kristensen LE; Wallman JK
    Rheumatology (Oxford); 2019 Jul; 58(7):1176-1187. PubMed ID: 30649509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRP and a biomarker of type I collagen degradation, C1M, can differentiate anti-inflammatory treatment response in ankylosing spondylitis.
    Siebuhr AS; Bay-Jensen AC; Karsdal MA; Lories RJ; de Vlam K
    Biomark Med; 2016; 10(2):197-208. PubMed ID: 26764293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
    Malaviya AN; Kalyani A; Rawat R; Gogia SB
    Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating protein fragments of cartilage and connective tissue degradation are diagnostic and prognostic markers of rheumatoid arthritis and ankylosing spondylitis.
    Bay-Jensen AC; Wichuk S; Byrjalsen I; Leeming DJ; Morency N; Christiansen C; Karsdal MA; Maksymowych WP
    PLoS One; 2013; 8(1):e54504. PubMed ID: 23365672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
    Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
    J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases?
    Wallis D; Haroon N; Ayearst R; Carty A; Inman RD
    J Rheumatol; 2013 Dec; 40(12):2038-41. PubMed ID: 24187102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis.
    Sagard J; Olofsson T; Mogard E; Marsal J; Andréasson K; Geijer M; Kristensen LE; Lindqvist E; Wallman JK
    Arthritis Res Ther; 2022 Feb; 24(1):42. PubMed ID: 35151357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome.
    Corli J; Flipo RM; Philippe P; Bera-Louville A; Béhal H; Wibaux C; Paccou J
    J Rheumatol; 2015 Dec; 42(12):2376-82. PubMed ID: 26568593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Biomarker of Collagen Degradation Can Identify Patients Affected With Both Axial Spondyloarthritis and Crohn Disease.
    Nielsen SH; Stahly A; Regner EH; Bay-Jensen AC; Karsdal MA; Kuhn KA
    J Rheumatol; 2022 Dec; 49(12):1335-1340. PubMed ID: 35705233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
    Glintborg B; Sørensen IJ; Østergaard M; Dreyer L; Mohamoud AA; Krogh NS; Hendricks O; Andersen LS; Raun JL; Kowalski MR; Danielsen L; Pelck R; Nordin H; Pedersen JK; Kraus DG; Christensen SR; Hansen IM; Esbesen J; Schlemmer A; Loft AG; Al Chaer N; Salomonsen L; Hetland ML
    J Rheumatol; 2017 Jan; 44(1):59-69. PubMed ID: 27909080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.
    Deodhar A; Strand V; Kay J; Braun J
    Ann Rheum Dis; 2016 May; 75(5):791-4. PubMed ID: 26768406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.